Affinity Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-18,250
Closed -$2.05M 151
2018
Q2
$2.05M Buy
18,250
+40
+0.2% +$4.32K 0.29% 81
2018
Q1
$1.94M Hold
18,210
0.23% 83
2017
Q4
$1.99M Hold
18,210
0.23% 87
2017
Q3
$1.97M Sell
18,210
-2,910
-14% -$299K 0.23% 79
2017
Q2
$2.14M Sell
21,120
-15,792
-43% -$1.45M 0.25% 85
2017
Q1
$3.32M Sell
36,912
-240
-0.6% -$20.4K 0.3% 88
2016
Q4
$2.83M Sell
37,152
-15,033
-29% -$1.14M 0.27% 94
2016
Q3
$4.35M Sell
52,185
-19,493
-27% -$1.63M 0.37% 82
2016
Q2
$5.91M Buy
71,678
+30,066
+72% +$2.48M 0.44% 79
2016
Q1
$3.16M Buy
+41,612
New +$3.08M 0.28% 83

Other funds holding CRL